Correlation Between Moleculin Biotech and Jaguar Animal

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Moleculin Biotech and Jaguar Animal at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Moleculin Biotech and Jaguar Animal into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Moleculin Biotech and Jaguar Animal Health, you can compare the effects of market volatilities on Moleculin Biotech and Jaguar Animal and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Moleculin Biotech with a short position of Jaguar Animal. Check out your portfolio center. Please also check ongoing floating volatility patterns of Moleculin Biotech and Jaguar Animal.

Diversification Opportunities for Moleculin Biotech and Jaguar Animal

0.34
  Correlation Coefficient

Weak diversification

The 3 months correlation between Moleculin and Jaguar is 0.34. Overlapping area represents the amount of risk that can be diversified away by holding Moleculin Biotech and Jaguar Animal Health in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Jaguar Animal Health and Moleculin Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Moleculin Biotech are associated (or correlated) with Jaguar Animal. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Jaguar Animal Health has no effect on the direction of Moleculin Biotech i.e., Moleculin Biotech and Jaguar Animal go up and down completely randomly.

Pair Corralation between Moleculin Biotech and Jaguar Animal

Given the investment horizon of 90 days Moleculin Biotech is expected to generate 0.92 times more return on investment than Jaguar Animal. However, Moleculin Biotech is 1.08 times less risky than Jaguar Animal. It trades about -0.15 of its potential returns per unit of risk. Jaguar Animal Health is currently generating about -0.17 per unit of risk. If you would invest  177.00  in Moleculin Biotech on November 3, 2024 and sell it today you would lose (26.00) from holding Moleculin Biotech or give up 14.69% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy95.24%
ValuesDaily Returns

Moleculin Biotech  vs.  Jaguar Animal Health

 Performance 
       Timeline  
Moleculin Biotech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Moleculin Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Jaguar Animal Health 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Jaguar Animal Health has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong technical and fundamental indicators, Jaguar Animal is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Moleculin Biotech and Jaguar Animal Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Moleculin Biotech and Jaguar Animal

The main advantage of trading using opposite Moleculin Biotech and Jaguar Animal positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Moleculin Biotech position performs unexpectedly, Jaguar Animal can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Jaguar Animal will offset losses from the drop in Jaguar Animal's long position.
The idea behind Moleculin Biotech and Jaguar Animal Health pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

Other Complementary Tools

CEOs Directory
Screen CEOs from public companies around the world
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Money Managers
Screen money managers from public funds and ETFs managed around the world
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency